Initial findings from the prospective, multi-center RELIEF Registry suggest that the use of spinal cord stimulation (SCS) is associated with close to 90% overall improvement in patient satisfaction and less than a 10% explant rate after 3 years, as presented at NeuPSIG 2019. Explants due to lack of efficacy were particularly rare (2.4%).